Fig. 3From: Time-dependent antagonist-agonist switching in receptor tyrosine kinase-mediated signalingSchematic diagram of the HER4-JAK2-STAT5 pathway modeled in this paper. More details are available in the Methods section. We introduced cytoplasmic and nuclear compartments and transport reactions between the compartments as indicated. The heterodimerization reactions are indicated with a side branch from HER4 and not shown explicitlyBack to article page